29th Congress of the European Association for Cancer Research (EACR 2025)

Topics

• Cancer Genomics, Epigenetics and Genomic Instability
  • Functional Genomics
  • Genomic Alterations in Cancer
  • Genetic instability
  • Epigenetic mechanisms and RNA
  • Deep sequencing
• Cell and Tumour Biology
  • Cell Death / Autophagy
  • Cell Proliferation/cell cycle
  • Tumour Progression: Invasion and Metastasis
  • Oncogenes and Tumour Suppressor Genes
  • Tumour Microenvironment
  • Metastases and EMT
  • Tumour Immunology AND Inflammation
  • Tumour Angiogenesis
  • Senescence
  • Aging and Cancer
  • Cancer Initiating Cells / Cancer Stem Cells
  • Cancer Cell Metabolism
  • Tumour heterogeneity
• Carcinogenesis
  • Promotion and Progression
  • Mutagenesis, Carcinogen Metabolism
  • Viral Oncogenesis
  • DNA Damage and Repair
• Signalling Pathways
  • Gene Expression, Transcriptional Regulation
  • Receptors and Signal Transduction
  • Computational models of biological systems
  • Systems biology
  • Omics technologies
• Experimental / Molecular Therapeutics, Pharmacogenomics
  • Novel Targets, Delivery Systems
  • Drug Discovery / Drug Design
  • Drug Resistance
  • Mechanisms of Drug Action, Drug Profiling
  • New Therapies
  • Novel Approaches to Diagnosis of Cancer
  • Personalized medicine
  • Companion diagnostics
• Translational Research
  • Molecular pathology
  • Organ Site-Specific Investigations: Preclinical, Diagnosis, Treatment
  • Prognostic biomarkers of therapy response
  • Biomarkers with clinical relevance, imaging
  • Clinical Phase I/II trials with targeted drugs and novel agents
  • Prognostic value of oncogenomics
  • Animal models of cancer
  • Bioinformatics in therapies and clinical trials
  • Infrastructures (biobanks, databases, genomic resources, others)
• Radiobiology / Radiation Oncology
  • Radiation-activated Signalling Pathways
  • Tumour Cell Sensitization to Radiotherapy
  • Radiation Oncology; Preclinical and Clinical
  • Cell Cycle and Apoptosis in Radiation Responses
  • Translational radiation research
• Tumour Immunology
  • Immune Suppression and Escape
  • Tumour Immunology
  • Immunotherapy and Cancer Vaccines
  • Tumour antigens and immune effectors
• Prevention and Early Detection
  • Clinical Prevention Studies
  • Preclinical Prevention Studies, Markers and Prevention
  • Vaccination Against Cancer
• Molecular and Genetic Epidemiology
  • Biomarkers
  • Risk Factors
  • Susceptibility Genes
  • Risk Assessment
  • Genetic Polymorphisms and Cancer Susceptibility
  • Genotype / Phenotype Correlations
  • Epidemiology